Spectrum Pharmaceuticals Revenue and Competitors

Location

$53M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Spectrum Pharmaceuticals's estimated annual revenue is currently $300M per year.(i)
  • Spectrum Pharmaceuticals's estimated revenue per employee is $1,507,538
  • Spectrum Pharmaceuticals's total funding is $53M.
  • Spectrum Pharmaceuticals's current valuation is $182.3M. (January 2022)

Employee Data

  • Spectrum Pharmaceuticals has 199 Employees.(i)
  • Spectrum Pharmaceuticals grew their employee count by -13% last year.

Spectrum Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Executive Director, National AccountsReveal Email/Phone
3
Executive Director National Accounts/SalesReveal Email/Phone
4
VP, Commercial OperationsReveal Email/Phone
5
VP Clinical OperationsReveal Email/Phone
6
SVP Research DevelopmentReveal Email/Phone
7
SVP, Sales MarketingReveal Email/Phone
8
VP, Business SolutionsReveal Email/Phone
9
Director Phamraceutical Manufacturing and Supply ChainReveal Email/Phone
10
Director, Statistical ProgrammingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$0.3M2-78%N/AN/A
#3
$3.5M13-13%$18MN/A
#4
$1.4M9-10%N/AN/A
#5
$11.8M7627%N/AN/A
#6
$4.2M2713%N/AN/A
#7
$9.3M609%N/AN/A
#8
$300M199-13%$53MN/A
#9
$2.6M176%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is Spectrum Pharmaceuticals?

NeoTherapeutics, Inc. is a development-stage biopharmaceutical company engaged in the discovery and development of novel therapeutic drugs intended to treat neurological diseases such as memory deficits associated with Alzheimer\'s disease and aging, spinal cord injuries,Parkinson\'s disease and other neurodegenerative and psychiatric diseases. The Company has also become engaged in research involving functional genomics and the development of oncology drugs.

keywords:N/A

$53M

Total Funding

199

Number of Employees

$300M

Revenue (est)

-13%

Employee Growth %

$182.3M

Valuation

N/A

Accelerator

Spectrum Pharmaceuticals News

2022-04-19 - Do Analysts Agree Monday on Spectrum Pharmaceuticals, Inc. (SPPI) Stock's Target Price?

(SPPI) Stock's Target Price. Analysts who follow Spectrum Pharmaceuticals, Inc. (SPPI) on average expect it to increase 644.68% over the next...

2022-04-06 - Spectrum Pharmaceuticals Announces FDA Acceptance of ...

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology...

2022-03-30 - Spectrum Pharmaceuticals Announces Poster Presentation at ...

Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$68.3M2149%N/A
#2
$63.6M2149%N/A
#3
$89.9M25310%N/A
#4
$51.7M2618%N/A
#5
$60M2669%N/A